Revolutionizing Clinical Trials: How Health Decision Science Is Changing the Game

When it comes to making health decisions, human behavior is complex and often unpredictable. This is why the field of health decision science has emerged, combining insights from behavioral economics, psychology, and neuroscience to understand and influence human decision-making.

But how does this apply to clinical trials?

Well, sponsors can use health decision science to improve trial recruitment and retention by identifying and addressing the motivations and barriers of patients, investigators, and site staff. By doing so, they can design more patient-centric trials that increase patient satisfaction, engagement, adherence, and retention.

Let's take a closer look at how health decision science can be applied in different phases of clinical trials.

Feasibility Assessment and Protocol Design

In the feasibility assessment and protocol design phase, health decision science can be used to identify and address the motivations and barriers of potential patients and investigators. For example, a study might uncover that potential patients are hesitant to participate in a trial because they are concerned about the time commitment or potential side effects. Sponsors can then adjust the trial design to address these concerns, such as reducing the frequency of visits or providing more information on the risks and benefits.

Site Selection and Patient Recruitment

In the site selection and patient recruitment phase, health decision science can help sponsors understand the decision-making process of site staff and potential patients. By understanding their motivations and barriers, sponsors can tailor their recruitment strategies and messaging to increase enrollment rates. For example, they could offer incentives to site staff for successful patient recruitment or use patient testimonials to increase trust and engagement.

Patient Retention

Finally, health decision science can also help sponsors optimize trial operations by enhancing communication, collaboration, feedback, and incentives among trial stakeholders. By understanding the motivations and barriers of patients, sponsors can design interventions that increase patient retention. For example, they could implement reminder systems, simplify study procedures, or provide additional support for patients experiencing side effects.

In conclusion, health decision science is a powerful framework that sponsors can use to improve clinical trial recruitment, retention, and operations. By applying insights from behavioral economics, psychology, and neuroscience, sponsors can design more patient-centric trials that increase engagement, satisfaction, adherence, and retention. By doing so, they can accelerate the development of new therapies and improve patient outcomes.